An increasing trend in CRE bacteremia cases was observed over the study period, particularly during 2023.
← all excerpts
Prognosis and Outcome of Carbapenem-Resistant Enterobacterales Bacteremia Managed With Ceftazidime-Avibactam and Aztreonam Combination Therapy in Tawam Hospital, UAE: A Retrospective Study.
1
—
—